We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
LivaNova
LIVN
$4.33B
| $2.83M | 0.01% |
45,829
-7,080
| -13% | -$501K |
|
|
TPC
977
Tutor Perini Cor
TPC
$5.13B
| $2.83M | 0.01% |
321,919
+245,848
| +323% | +$2.37M |
|
|
AXON
978
Axon Enterprise
AXON
$51.7B
| $2.8M | 0.01% |
30,519
+215
| +0.7% | +$22.7K |
|
979
Lamar Advertising Co
LAMR
$15.6B
| $2.79M | 0.01% |
32,006
-75,837
| -70% | -$7.69M |
|
|
DCH
980
Dauch Corp
DCH
$1.64B
| $2.77M | 0.01% |
367,243
+149,803
| +69% | +$1.13M |
|
981
W.P. Carey
WPC
$15.9B
| $2.75M | 0.01% |
33,901
+1,024
| +3% | +$82.6K |
|
982
Petrobras Class A
PBR.A
$103B
| $2.74M | 0.01% |
257,988
+10,323
| +4% | +$130K |
|
|
WSR
983
DELISTED
Whitestone REIT
WSR
| $2.74M | 0.01% |
254,917
-11,808
| -4% | -$142K |
|
984
BlueLinx
BXC
$706M
| $2.74M | 0.01% |
40,946
+21,970
| +116% | +$1.65M |
|
985
Buckle
BKE
$2.37B
| $2.73M | 0.01% |
98,618
+12,275
| +14% | +$385K |
|
|
BHVN
986
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.73M | 0.01% |
18,737
-2,344
| -11% | -$299K |
|
987
MaxLinear
MXL
$6.26B
| $2.72M | 0.01% |
80,173
+24,254
| +43% | +$1.02M |
|
988
Broadridge
BR
$19.5B
| $2.72M | 0.01% |
19,231
-14,174
| -42% | -$2.06M |
|
|
COWN
989
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.71M | 0.01% |
114,539
+17,282
| +18% | +$420K |
|
990
Bank of Hawaii
BOH
$3.13B
| $2.71M | 0.01% |
37,222
-12,236
| -25% | -$942K |
|
|
LYLT
991
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $2.7M | 0.01% |
761,976
+592,305
| +349% | +$6.34M |
|
|
TBRG
992
DELISTED
TruBridge
TBRG
| $2.69M | 0.01% |
84,260
-7,712
| -8% | -$250K |
|
993
AptarGroup
ATR
$8.57B
| $2.69M | 0.01% |
26,327
+266
| +1% | +$29K |
|
|
MCHB
994
Mechanics Bancorp
MCHB
$3.8B
| $2.69M | 0.01% |
77,532
+13,792
| +22% | +$555K |
|
995
Nasdaq
NDAQ
$53.1B
| $2.68M | 0.01% |
53,187
-45,945
| -46% | -$2.43M |
|
996
Safe Bulkers
SB
$746M
| $2.67M | 0.01% |
699,564
+475,815
| +213% | +$2.03M |
|
|
BRY
997
DELISTED
Berry Corp
BRY
| $2.66M | 0.01% |
349,381
+173,657
| +99% | +$1.83M |
|
998
Cushman & Wakefield Ltd
CWK
$3.23B
| $2.66M | 0.01% |
174,541
+60,193
| +53% | +$1.06M |
|
999
Community Trust Bancorp
CTBI
$1.42B
| $2.65M | 0.01% |
65,490
+1,877
| +3% | +$76.4K |
|
1000
Cullen/Frost Bankers
CFR
$10.3B
| $2.64M | 0.01% |
23,110
+6,805
| +42% | +$869K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.